Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients

NCT01347983 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Tocilizumab+Methotrexate(MTX)

Sponsor

Chugai Pharma Taiwan